Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
about
BRCA1 is an essential regulator of heart function and survival following myocardial infarctionTargeting ATM-deficient CLL through interference with DNA repair pathwaysDistribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast CancerMapping of Mcs30, a new mammary carcinoma susceptibility quantitative trait locus (QTL30) on rat chromosome 12: identification of fry as a candidate Mcs geneBARD1 may be renamed ROW1 because it functions mainly as a REPRESSOR OF WUSCHEL1The DNA Damage Response: Making It Safe to Play with KnivesRAD51C germline mutations in breast and ovarian cancer cases from high-risk familiesEvolution of pre-existing versus acquired resistance to platinum drugs and PARP inhibitors in BRCA-associated cancersNovel germline PALB2 truncating mutations in African American breast cancer patientsA Frailty-Model-Based Method for Estimating Age-Dependent Penetrance from Family Data.Free the DataIntegrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast CancerNovel sequence variants and a high frequency of recurrent polymorphisms in BRCA1 gene in Sri Lankan breast cancer patients and at risk individuals.Hereditary breast cancer: ever more pieces to the polygenic puzzle.Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.The validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay.Functional and mutational landscapes of BRCA1 for homology-directed repair and therapy resistancePIK3CA and TP53 gene mutations in human breast cancer tumors frequently detected by ion torrent DNA sequencing.Chemopreventive Activity of Honokiol against 7, 12 - Dimethylbenz[a]anthracene-Induced Mammary Cancer in Female Sprague Dawley Rats.Analysis of BRCA1and BRCA2 large genomic rearrangements in Sri Lankan familial breast cancer patients and at risk individualsMicroRNAs discriminate familial from sporadic non-BRCA1/2 breast carcinoma arising in patients ≤35 years.Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer.A BRCA1-mutation associated DNA methylation signature in blood cells predicts sporadic breast cancer incidence and survival.Role of 5'- and 3'-untranslated regions of mRNAs in human diseases.Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.Cell death or survival: The double-edged sword of environmental and occupational toxicity.Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing.Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules.Evolutionary pathways in BRCA1-associated breast tumors.Nuclear nano-morphology markers of histologically normal cells detect the "field effect" of breast cancer.Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study.Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.Deletion of chromosomes 13q and 14q is a common feature of tumors with BRCA2 mutations.Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).Missense variants of uncertain significance (VUS) altering the phosphorylation patterns of BRCA1 and BRCA2.BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families.CDDO-imidazolide induces DNA damage, G2/M arrest and apoptosis in BRCA1-mutated breast cancer cells
P2860
Q24300290-D9963063-A28F-409E-8D29-36AF20DC9D4FQ26822592-63B72ACF-016B-4454-8EAA-142D9B039ECDQ27023165-E677E49C-A8BD-4009-8E2E-257501FE16F9Q27309935-665B3FD6-3D93-421C-A29D-F9CF5820ACCAQ27487849-2AFAF47E-3966-4696-BDAE-166FD150EA95Q27861055-E5D8821C-FE84-40D3-A875-1BCB46C0F25CQ28249994-AC61C9C2-20D2-4D24-B0A6-515722CC9AEFQ28542563-86D85727-A07C-41C6-8CDB-34FBF2530FDCQ28741002-DF10EF1F-A8A9-4C9B-B72B-D6520B5BF05FQ30705168-3534DBB8-C096-44D9-9B86-BE213A3799E3Q30728592-B54FFCA7-E378-4A55-B1AB-E751D8AFC140Q31132980-17318642-8F21-497C-BDA7-562FC9488839Q33355677-FAC7AC65-D16F-4401-9F62-7FA2ADFBE540Q33356511-DA26A5E9-F191-4B3E-8A73-A2EF4A349C1FQ33506772-A975A959-B176-42DC-9D7D-72E6B41A62D0Q33618536-8DAD99CA-5CD3-4393-8F50-DF2B8D101BFEQ33688407-DDDD7682-992B-4EE3-A9A5-9C83CCC4A5C4Q33740638-5E6B6E4E-5DC1-41B0-A4BD-A5E2A0C526D3Q33742294-9E4238C4-5A78-48E8-AC8A-A7732071570EQ33755042-F09EC68B-649E-4EAE-A832-580B0E506ABCQ33875195-0E3A221D-5A92-42DA-9701-64F0CF0C554BQ33889288-983DC966-35CE-4D95-8C9F-4528EED268B0Q33896012-24B0ED8F-6812-47E1-AF0A-616C2AAB91E0Q33948754-C2D27165-BB05-417B-AAA0-792606299120Q34016479-CB7B701B-80B1-4FFC-B05B-4777AD2B5766Q34077422-3A76F491-DDE5-47AE-9609-3C661EFE8515Q34143322-04987E87-126D-4749-A5CE-CC713C80E231Q34228853-CED670F4-4BB1-49E1-919D-C691BA85530FQ34243783-E81517F0-798E-408D-99C3-D8F613DE4751Q34277174-12690F83-FC1A-4983-AE67-86509D2B89E4Q34307174-4D596D58-41BF-4EE7-8851-590F0D714163Q34400764-15BE7419-E0A9-4612-86BB-3239796976B0Q34412163-0994A808-D7C8-4CEE-8536-2F058A313E3CQ34530426-A1F88720-D43C-46BD-82A9-91C385272C41Q34532927-41641468-DC62-4C81-BF42-F140E0D3EAEAQ34613122-72F9DC85-7077-4ED4-A246-FAC3A3063899Q34727387-F454CCE2-DA51-4CCA-862F-3D04A4B00039Q34737253-5A512D9E-0E47-469C-B8AA-98DF68422EC0Q34773464-C05AE85B-4396-4982-9DC5-D74852E6FE20Q34793556-C68CD79E-1073-4370-8603-0E5DCF999331
P2860
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
@en
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
@nl
type
label
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
@en
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
@nl
prefLabel
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
@en
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
@nl
P356
P1476
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
@en
P2093
James D Fackenthal
P2888
P304
P356
10.1038/NRC2054
P407
P577
2007-12-01T00:00:00Z